Impact of infant 13-valent pneumococcal conjugate vaccine on serotypes in adult pneumonia

The European Respiratory Journal
Chamira RodrigoWei Shen Lim

Abstract

Infant 13-valent pneumococcal conjugate vaccination (PCV13) was introduced to the UK in 2010. Its impact on serotypes implicated in adult non-bacteraemic pneumococcal pneumonia is not known. Beginning in 2008, a 5-year prospective cohort study of adults admitted to hospital with community-acquired pneumonia (CAP) was conducted. Pneumococcal serotype was established using a validated multiplex immunoassay (Bio-Plex; Bio-Rad, Hercules, CA, USA). The overall incidence for hospitalised CAP and pneumococcal CAP was 79.9 (95% CI 76.6-83.3) and 23.4 (95% CI 21.6-25.3) per 100,000 population, respectively. A decline in CAP (incidence rate ratio (IRR) per year 0.96, 95% CI 0.94-0.99; p=0.016) and pneumococcal CAP (IRR per year 0.84, 95% CI 0.80-0.89; p<0.001) was observed over the 5-year period of the study. Between the pre- and post-PCV13 periods of the study, the incidence of CAP due to serotypes included in the PCV7 declined by 88% (IRR 0.12, 95% CI 0.08-0.20; p<0.001), and CAP due to the additional 6 serotypes in PCV13 declined by 30% (IRR 0.70, 95% CI 0.51-0.96; p=0.024). Incidence of adult pneumococcal pneumonia declined over the last 5 years, with serotypes included in PCV13 declining post-PCV13 introduction, indicating early her...Continue Reading

References

Aug 13, 2004·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Daniel M MusherAnna Wanahita
May 20, 2005·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·M M van der EerdenW G Boersma
Aug 29, 2006·Annals of Emergency Medicine·Matthew C StrehlowCarlos A Camargo
Apr 29, 2008·Emerging Infectious Diseases·Caroline L TrotterElizabeth Miller
Dec 2, 2009·The Journal of Infectious Diseases·Tamara PilishviliUNKNOWN Active Bacterial Core Surveillance/Emerging Infections Program Network
Mar 27, 2012·The Journal of Infectious Diseases·Peter C WroeSusan S Huang
Oct 30, 2012·BMJ : British Medical Journal·Mark H RozenbaumW John Edmunds
Jul 12, 2013·The New England Journal of Medicine·Marie R GriffinCarlos G Grijalva
Feb 18, 2014·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·F AngoulvantR Cohen
May 8, 2014·Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy·Hayato OkadeHiroshige Mikamo
Aug 30, 2014·Perspectives in Public Health·Anthony KesselNaima Bradley

❮ Previous
Next ❯

Citations

Feb 26, 2016·The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care·Alexander Kuhlmann, J-Matthias Graf von der Schulenburg
May 14, 2016·Vaccine·Cornelis H van WerkhovenMarc J M Bonten
May 14, 2016·BMC Pulmonary Medicine·James D ChalmersHarish Madhava
Oct 21, 2016·European Journal of Internal Medicine·Francesco BlasiAntoni Torres
Dec 18, 2016·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Sanjay JayasinghePeter McIntyre
Dec 29, 2016·International Journal of Molecular Sciences·Nicola Principi, Susanna Esposito
Jan 31, 2017·Vaccines·Marco Cavallari, Gennaro De Libero
Feb 16, 2017·Current Opinion in Pulmonary Medicine·Ricardo J José, Jeremy S Brown
Dec 14, 2016·The Lancet Global Health·David Goldblatt
Mar 15, 2018·Current Opinion in Pulmonary Medicine·Carlos M LunaDiego Burgos
Dec 7, 2018·Expert Review of Respiratory Medicine·Charles Feldman, Erica Shaddock
Oct 13, 2018·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Nirma Khatri VadlamudiFawziah Marra
Mar 23, 2017·ERJ Open Research·Priya DanielWei Shen Lim
Nov 24, 2017·American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists·Gregory S King, William R Judd
Apr 24, 2019·Aging and Disease·Fawziah Marra, Nirma Khatri Vadlamudi
Jul 16, 2019·Expert Review of Vaccines·Viviane Maimoni GonçalvesEliane Namie Miyaji
Jan 11, 2018·Pneumonia·Paul Van Buynder, Robert Booy
Nov 23, 2019·Thorax·David Goldblatt, Elizabeth Miller
Nov 6, 2018·PloS One·Andreia N HorácioUNKNOWN Portuguese Group for the Study of Streptococcal Infections
Nov 17, 2019·Thorax·Frances Susanna GrudzinskaElizabeth Sapey
Aug 8, 2019·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Kelley N MederPeter McIntyre
Jan 25, 2017·The Cochrane Database of Systematic Reviews·Julia Ae WaltersRichard Wood-Baker
May 16, 2020·F1000Research·Charles Feldman, Ronald Anderson

❮ Previous
Next ❯

Related Concepts

Related Feeds

Bacterial Pneumonia

Bacterial pneumonia is a prevalent and costly infection that is a significant cause of morbidity and mortality in patients of all ages. Here is the latest research.

Bacterial Pneumonia (ASM)

Bacterial pneumonia is a prevalent and costly infection that is a significant cause of morbidity and mortality in patients of all ages. Here is the latest research.